Shiro Akinaga
Vorstandsvorsitzender bei NANO MRNA CO.,LTD.
Vermögen: 90 589 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Tetsuhito Matsuyama | M | 61 | 10 Jahre | |
Koji Fujimoto | M | 51 | 22 Jahre | |
Kazunori Kataoka | M | 73 | 28 Jahre | |
Teruo Okano | M | 75 | 28 Jahre | |
Keiko Hattori | F | - |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | 7 Jahre |
Atsushi Matsumura | M | 62 | 12 Jahre | |
Satoru Iino | M | 58 | 12 Jahre | |
Hiromichi Kimura | M | 73 |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | - |
Tomohiro Anzai | M | - |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | - |
Mikio Kawahara | M | - |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | 7 Jahre |
Yuki Hasegawa | M | 46 | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Takashi Kawai | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Japan | 12 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Shiro Akinaga
- Persönliches Netzwerk